本页面由Tiger Trade Technology Pte. Ltd.提供服务

福泰制药

507.00
-3.0800-0.60%
盘后:507.000.00000.00%19:49 EDT
成交量:95.27万
成交额:4.85亿
市值:1,286.35亿
市盈率:29.51
高:514.80
开:512.44
低:506.00
收:510.08
52周最高:560.25
52周最低:402.58
股本:2.54亿
流通股本:2.54亿
量比:0.87
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):17.18
每股收益(LYR):15.32
净资产收益率:23.54%
总资产收益率:11.93%
市净率:6.35
市盈率(LYR):33.09

数据加载中...

2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities